Yinting Chen Selected Research

Single-Chain Antibodies

2/2020	Nanoparticles modified by triple single chain antibodies for MRI examination and targeted therapy in pancreatic cancer.
8/2016	A Nanoparticle Carrier for Co-Delivery of Gemcitabine and Small Interfering RNA in Pancreatic Cancer Therapy.
3/2015	Effective suppression of the Kirsten rat sarcoma viral oncogene in pancreatic tumor cells via targeted small interfering RNA delivery using nanoparticles.
8/2013	Suppression of pancreatic tumor growth by targeted arsenic delivery with anti-CD44v6 single chain antibody conjugated nanoparticles.
1/2012	Development of an MRI-visible nonviral vector for siRNA delivery targeting gastric cancer.
6/2010	Generation of a stable anti-human CD44v6 scFv and analysis of its cancer-targeting ability in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yinting Chen Research Topics

Disease

12	Neoplasms (Cancer) 05/2022 - 03/2010
9	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 08/2013
6	Stomach Neoplasms (Stomach Cancer) 01/2020 - 03/2010
4	Neoplasm Metastasis (Metastasis) 01/2020 - 04/2016
3	Adenocarcinoma 01/2021 - 06/2010
3	Carcinoma (Carcinomatosis) 01/2021 - 03/2010
1	Melanoma (Melanoma, Malignant) 01/2021
1	Acute Liver Failure (Fulminant Hepatic Failure) 02/2018
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2015
1	T-Cell Lymphoma (Lymphoma, T Cell) 11/2015
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2015
1	Sarcoma (Soft Tissue Sarcoma) 03/2015

Drug/Important Bio-Agent (IBA)

6	Single-Chain AntibodiesIBA 02/2020 - 06/2010
6	Small Interfering RNA (siRNA)IBA 08/2016 - 03/2010
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2013
4	PolyethyleneimineIBA 07/2017 - 03/2010
3	Gemcitabine FDA Link 01/2021 - 08/2016
3	Biological ProductsIBA 01/2018 - 03/2015
3	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 07/2013 - 03/2010
2	Pharmaceutical PreparationsIBA 01/2021 - 08/2013
2	Therapeutic UsesIBA 01/2021 - 08/2016
2	CytokinesIBA 01/2021 - 01/2018
2	raf KinasesIBA 01/2020 - 04/2016
2	MicroRNAs (MicroRNA)IBA 07/2019 - 12/2017
2	ArsenicIBA 02/2014 - 08/2013
2	AntigensIBA 08/2013 - 06/2010
1	AntibodiesIBA 05/2022
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 05/2022
1	Interleukin-6 (Interleukin 6)IBA 05/2022
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	ChemokinesIBA 01/2021
1	Carcinoembryonic AntigenIBA 01/2020
1	human MIRN623 microRNAIBA 07/2019
1	Acetaminophen (Paracetamol)FDA LinkGeneric 02/2018
1	Messenger RNA (mRNA)IBA 12/2017
1	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 12/2017
1	Antisense OligonucleotidesIBA 07/2017
1	ferric oxide (iron oxide)IBA 07/2017
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2015
1	AlbuminsIBA 11/2015
1	BromidesIBA 03/2015
1	ImmunosorbentsIBA 03/2015
1	AgarIBA 03/2015
1	EnzymesIBA 03/2015
1	Antineoplastic Agents (Antineoplastics)IBA 08/2013
1	Arsenic Trioxide (Trisenox)FDA Link 08/2013
1	Protein Isoforms (Isoforms)IBA 07/2013
1	poly(ethylene glycol)-co-poly(ethyleneimine)IBA 03/2010
1	PolymersIBA 03/2010

Therapy/Procedure

6	Therapeutics 02/2020 - 06/2010
4	Drug Therapy (Chemotherapy) 07/2017 - 11/2015
1	Immunotherapy 01/2021
1	Oncolytic Virotherapy 01/2021
1	Precision Medicine 08/2016